back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-05 16:12 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-16,973 vol |
89,108 | |
| Filed 2024-03-05 16:11 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,706 vol |
106,081 | |
| Filed 2024-03-05 16:11 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-31,706 vol |
417,110 | |
| Filed 2024-03-05 16:10 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-5,994 vol |
74,375 | |
| Filed 2024-03-05 16:09 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,197 vol |
80,369 | |
| Filed 2024-03-05 16:08 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,197 vol |
448,816 | |
| Filed 2024-03-05 16:07 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-511 vol |
69,172 | |
| Filed 2024-03-05 16:07 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+953 vol |
69,683 | |
| Filed 2024-03-05 16:06 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-953 vol |
460,013 | |
| Filed 2024-03-05 16:05 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-765 vol |
68,730 | |
| Filed 2024-03-05 16:03 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,429 vol |
69,495 | |
| Filed 2024-03-05 16:03 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,429 vol |
460,966 | |
| Filed 2024-03-04 18:22 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+147,536 vol |
462,395 | |
| Filed 2023-12-05 16:28 Tx date 2023-12-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-220 vol |
68,066 | |
| Filed 2023-12-05 16:27 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,691 vol |
68,286 | |
| Filed 2023-12-05 16:26 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,158 vol |
69,977 | |
| Filed 2023-12-05 16:26 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
314,859 | |
| Filed 2023-11-07 17:41 Tx date 2023-11-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-327.23
-43 vol $7.61 each |
66,819 | |
| Filed 2023-11-07 17:40 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,528.38
-334 vol $7.57 each |
66,862 | |
| Filed 2023-11-07 17:39 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,716
+623 vol $7.57 each |
67,196 | |
| Filed 2023-11-07 17:38 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-4,716.11
-623 vol $7.57 each |
318,017 | |
| Filed 2023-09-07 10:50 Tx date 2023-09-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,351.80
-6,685 vol $8.28 each |
66,573 | |
| Filed 2023-09-07 10:48 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-428,663.95
-51,337 vol $8.35 each |
73,258 | |
| Filed 2023-09-07 10:47 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800,781
+95,902 vol $8.35 each |
124,595 | |
| Filed 2023-09-07 10:47 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-95,902 vol |
318,640 | |
| Filed 2023-03-06 18:55 Tx date 2023-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,539.15
-495 vol $9.17 each |
28,693 | |
| Filed 2023-03-06 18:54 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,285.20
-780 vol $9.34 each |
29,188 | |
| Filed 2023-03-06 18:52 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,680.76
-511 vol $9.16 each |
29,968 | |
| Filed 2023-03-06 18:51 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,729
+953 vol $9.16 each |
30,479 | |
| Filed 2023-03-06 18:51 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,007.40
-765 vol $9.16 each |
29,526 | |
| Filed 2023-03-06 18:50 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,089
+1,429 vol $9.16 each |
30,291 | |
| Filed 2023-03-06 18:49 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,124.92
-887 vol $9.16 each |
28,862 | |
| Filed 2023-03-06 18:48 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,178
+1,657 vol $9.16 each |
29,749 | |
| Filed 2023-03-06 18:47 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,994.92
-1,637 vol $9.16 each |
28,092 | |
| Filed 2023-03-06 18:46 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,286
+3,058 vol $9.25 each |
29,729 | |
| Filed 2023-03-06 18:45 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-953 vol |
414,542 | |
| Filed 2023-03-06 18:45 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,429 vol |
415,495 | |
| Filed 2023-03-06 18:44 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,657 vol |
0 | |
| Filed 2023-03-06 18:43 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,058 vol |
1,657 | |
| Filed 2023-03-06 18:41 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-55,444.50
-5,994 vol $9.25 each |
26,671 | |
| Filed 2023-03-06 18:41 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$103,572
+11,197 vol $9.25 each |
32,665 | |
| Filed 2023-03-06 18:40 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,197 vol |
416,924 | |
| Filed 2023-03-06 18:38 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$879,850
+95,119 vol $9.25 each |
428,121 | |
| Filed 2023-03-06 18:37 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+82,117 vol |
265,698 | |
| Filed 2023-03-01 18:34 Tx date 2023-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,721.44
-292 vol $9.32 each |
21,468 | |
| Filed 2023-03-01 18:33 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,349.76
-768 vol $9.57 each |
21,760 | |
| Filed 2023-03-01 18:32 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,723
+1,434 vol $9.57 each |
22,528 | |
| Filed 2023-03-01 18:32 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,434 vol |
333,002 | |
| Filed 2023-03-01 18:30 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,106.18
-1,474 vol $9.57 each |
21,094 | |
| Filed 2023-03-01 18:30 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$26,336
+2,752 vol $9.57 each |
22,568 | |
| Filed 2023-03-01 18:29 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,752 vol |
4,715 | |
| Filed 2022-12-02 12:42 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-13,020.70
-1,691 vol $7.70 each |
19,816 | |
| Filed 2022-12-02 12:31 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-11,295.90
-1,467 vol $7.70 each |
||
| Filed 2022-12-02 12:30 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,316
+3,158 vol $7.70 each |
21,507 | |
| Filed 2022-12-02 12:30 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
334,436 | |
| Filed 2022-11-07 15:35 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,154.30
-334 vol $6.45 each |
18,349 | |
| Filed 2022-11-07 15:34 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,018
+623 vol $6.45 each |
18,683 | |
| Filed 2022-11-07 15:33 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-623 vol |
337,594 | |
| Filed 2022-09-08 11:07 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+287,707 vol |
338,217 | |
| Filed 2022-05-16 16:51 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$44,321
+4,715 vol $9.40 each |
7,467 | |
| Filed 2022-05-16 16:50 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$25,868
+2,752 vol $9.40 each |
2,752 | |
| Filed 2022-05-16 16:49 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-13 19:05 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
183,581 | ||
| Filed 2022-05-13 19:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
50,510 | ||
| Filed 2022-05-13 19:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,060 |